by Sumeet Singh | Jun 5, 2020 | Accreditation, Industry News, NABP, PBM
Optum Rx & NABP DDA Lawsuit Update Optum Rx’s requirement for their network pharmacies to only purchase prescription drug and diabetic testing supplies from Accredited wholesalers has caused significant disruption and controversy since its implementation in August...
by Sumeet Singh | May 20, 2020 | Industry News
Top 5 Most Common PSL Findings Overview: NABP DDA accreditation consists of three main parts, which are the application review, policy & procedure review, and the on-site survey. In the application review, NABP reviews materials submitted with the application,...
by Sumeet Singh | May 20, 2020 | California, Drug Price Transparency, Minnesota, Nevada, State Compliance Requirements, State Regulation
Drug Pricing Transparency Fight Rages On Even as the COVID-19 pandemic disrupts day-to-day life, the fight over drug pricing transparency rages on between consumer groups, regulators, and industry. Regulators are assessing significant fines to increase compliance....
by Sumeet Singh | May 20, 2020 | Industry News
Shipping Office Stock vs. Prescriptions: $15M Case Study for Omnicare Omnicare, a leading provider of closed-door pharmacy services, agreed to pay more than a $15 million civil penalty for allowing opioids and other controlled substances to be dispensed without a...
by Sumeet Singh | May 11, 2020 | Company News, Puerto Rico, State Regulation
Pharma Solutions Submits Comments on New PR Rule Pharma Solutions is making public comments on the Puerto Rico Department of Health’s proposed regulation Number 156B titled For the Operation of Establishments that Manufacture, Distribute, and Dispatch Medications in...
